Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Visiontech CDI Forus
AddedMar 20, 2024
UpdatedJun 18, 2026
Visiontech CDI Forus

Visiontech CDI Forus

Public

Alpharetta-based manufacturer of innovative contact lenses.

HQ
Alpharetta, GA, US
Overview
Compare
Employees
Website

Founded in 2008 and based in Alpharetta, Georgia, Visioneering Technologies, Inc. (VTI) is dedicated to redefining vision care through innovative contact lens solutions. The company's core mission is to enhance the quality of life for individuals with myopia and presbyopia by providing advanced optical products. VTI's flagship product, NaturalVue®, is a multifocal contact lens designed for both adults and children, addressing the growing needs of these demographics across North America, Europe, and the Asia-Pacific regions.

Notable figures associated with VTI include its experienced team of optical engineers and medical professionals who drive the company's innovation. The company has garnered significant attention from investors and practitioners alike for its groundbreaking work in vision correction. Key achievements include widespread adoption of NaturalVue® lenses and expansion into multiple international markets. VTI's impact is evident in its contribution to improving vision health and offering effective solutions for common eye conditions globally.

Visiontech CDI Forus - Quick Facts

Where is Visiontech CDI Forus' headquarters located?

Visiontech CDI Forus' headquarters is located in Alpharetta, GA, US.

How many employees does Visiontech CDI Forus have?

Visiontech CDI Forus has 2 employees as of Mar 1, 2024.

Visiontech CDI Forus - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Consumers
Main Product
  • Contact Lenses
Tags
  • Healthtech
NAICS
  • 339100Medical Equipment and Supplies Manufacturing
  • 339110Medical Equipment and Supplies Manufacturing
  • 339115Ophthalmic Goods Manufacturing
  • 330000Manufacturing
  • 339000Miscellaneous Manufacturing
SIC
  • 3820Laboratory Apparatus And Analytical, Optical, Measuring, And Control
  • 3827Optical Instruments And Lenses
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified